Innovative Diagnostics

Pathogen ID in 30 minutes in pneumonia- and sepsis infections

Miacom was founded in 2009 with the mission to develop a novel and rapid diagnostic platform that will help physicians deliver timely and targeted antibiotic therapy decisions for critical care patients.

Our multiplex assays identify and differentiate most of the microorganisms causing life-threatening conditions such as sepsis and pneumonia. The rapid identification of microorganisms will help improve patient outcomes, reduce healthcare costs associated with lengthy hospitalizations, slow down the spread of antibiotic resistance among patients and most importantly save lives.

Our multiplex assays can identify up to 14 clinically relevant pathogens causing sepsis and pneumonia. Clinical samples such as positive blood culture and sputum can be used directly in our tests and the time to results is just 30 minutes.

New automated solution

Take advantage of our innovative diagnostic methods

Learn more

Meet us in person

DRG Forum

23.03.2017 - 24.03.2017

Meet us at DRG Forum in Berlin. For further information please contact us via


22.04.2017 - 25.04.2017

Meet us at ECCMID 2017 in Vienna, booth 57. For further information please contact us via

ASM Microbe

01.06.2017 - 05.06.2017

Meet us at ASM Microbe in New Orleans. For further information please contact us via